Carcinogen metabolism, cigarette smoking, and breast cancer risk: a Bayes model averaging approach

Epidemiologic Perspectives & Innovations - 2010
Nadine Stephenson1, Lars Beckmann1, Jenny Chang‐Claude1
1Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Tóm tắt

AbstractBackgroundStandard logistic regression with or without stepwise selection has the disadvantage of not incorporating model uncertainty and the dependency of estimates on the underlying model into the final inference. We explore the use of a Bayes Model Averaging approach as an alternative to analyze the influence of genetic variants, environmental effects and their interactions on disease.MethodsLogistic regression with and without stepwise selection and Bayes Model Averaging were applied to a population-based case-control study exploring the association of genetic variants in tobacco smoke-related carcinogen pathways with breast cancer.ResultsBoth regression and Bayes Model Averaging highlighted a significant effect ofNAT1*10 on breast cancer, while regression analysis also suggested a significant effect for packyears and for the interaction of packyears andNAT2.ConclusionsBayes Model Averaging allows incorporation of model uncertainty, helps reduce dimensionality and avoids the problem of multiple comparisons. It can be used to incorporate biological information, such as pathway data, into the analysis. As with all Bayesian analysis methods, careful consideration must be given to prior specification.

Từ khóa


Tài liệu tham khảo

Conti DV, Cortessis V, Molitor J, Thomas DC: Bayesian modeling of complex metabolic pathways. Hum Hered 2003, 56:83–93.

Greenland S: Bayesian perspectives for epidemiological research. II. Regression analysis. Int J Epidemiol 2007, 36:195–202.

Chang-Claude J, Kropp S, Jager B, Bartsch H, Risch A: Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11:698–704.

Kropp S: The Association between Tobacco Exposure and Breast Cancer Risk considering potentially modifying Effects of specific Genotypes. In PhD Thesis. University of Heidelberg; 2001.

Kropp S, Chang-Claude J: Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol 2002, 156:616–626.

Hastie TJ, Pregibon D: Generalized linear models. 1992.

Gelman A: Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 2006, 1:515–533.

Spiegelhalter DJ: WinBUGS version 2.10. 2005.

Raftery AE: Bayes Factors. J Am Statist Assoc 1995, 90:773–795.

Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, Sellers TA, Folsom AR, Hein DW: N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999, 8:233–239.

Millikan RC: NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000, 9:217–219.

Loktionov A, Moore W, Spencer SP, Vorster H, Nell T, O'Neill IK, Bingham SA, Cummings JH: Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention. Cancer Detect Prev 2002, 26:15–22.

Hughes NC, Janezic SA, McQueen KL, Jewett MA, Castranio T, Bell DA, Grant DM: Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 1998, 8:55–66.

Payton MA, Sim E: Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants. Biochem Pharmacol 1998, 55:361–366.

Bruhn C, Brockmoller J, Cascorbi I, Roots I, Borchert HH: Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Biochem Pharmacol 1999, 58:1759–1764.

Yang M, Katoh T, Delongchamp R, Ozawa S, Kohshi K, Kawamoto T: Relationship between NAT1 genotype and phenotype in a Japanese population. Pharmacogenetics 2000, 10:225–232.

Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF: Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 1995, 55:5230–5237.

Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC: Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995, 55:3537–3542.

van der Hel OL, Bueno-de-Mesquita HB, van Gils CH, Roest M, Slothouber B, Grobbee DE, Peeters PH: Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). Cancer Causes Control 2005, 16:675–681.

Gauderman J, Morrison J, QUANTO: A computer program for power and sample size calculations for genetic-epidemiology studies. (1.2.4). 2006.

Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J: Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:15–26.

Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, et al.: Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2004, 13:1473–1479.

Terry PD, Goodman M: Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:602–611.

Thông tin
Thông tin xuất bản

Epidemiologic Perspectives & Innovations

Thông tin tác giả